Dystrophic Epidermolysis Bullosa clinical trials

Explore recruiting dystrophic epidermolysis bullosa clinical trials.

Recruiting dystrophic epidermolysis bullosa studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dystrophic Epidermolysis Bullosa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I/II ex vivo gene therapy clinical trial for RDEB using autologous skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase II, Open Study to Assess Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis bullosa associated Locally Advanced/Metastatic Squamous Cell Carcinoma

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A double-blind, randomized, placebo-controlled, interventional, multicenter, phase III clinical trial to investigate the safety and efficacy of ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs) on epidermolysis bullosa (EB)

Austria, Hungary, Poland, Italy, Germany, Denmark +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dystrophic Epidermolysis Bullosa trials by city

Dystrophic Epidermolysis Bullosa in Toronto Dystrophic Epidermolysis Bullosa in Vancouver Dystrophic Epidermolysis Bullosa in Montreal Dystrophic Epidermolysis Bullosa in Calgary Dystrophic Epidermolysis Bullosa in Edmonton Dystrophic Epidermolysis Bullosa in Ottawa Dystrophic Epidermolysis Bullosa in Winnipeg Dystrophic Epidermolysis Bullosa in Quebec City Dystrophic Epidermolysis Bullosa in Hamilton Dystrophic Epidermolysis Bullosa in Kitchener Dystrophic Epidermolysis Bullosa in London Dystrophic Epidermolysis Bullosa in Halifax Dystrophic Epidermolysis Bullosa in New York Dystrophic Epidermolysis Bullosa in Los Angeles Dystrophic Epidermolysis Bullosa in Chicago Dystrophic Epidermolysis Bullosa in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease